This is a news story, published by Wired, that relates primarily to Wegovy news.
For more Wegovy news, you can click here:
more Wegovy newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Wired, you can click here:
more news from WiredOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
semaglutide medicines. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest brand medications news, semaglutide market news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Novo NordiskWired
•Health
Health
72% Informative
Semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy , has been on the FDA ’s shortage list since March 2022 .
In the intervening years , a lucrative industry of telehealth companies, medical spas, and pharmacies making and selling “compounded” copies of the medications.
These off-brand copies are sold at a steep discount—sometimes under $ 100 a vial—compared to the name-brand medications.
You’ve already got a whole population of compounders out there that are making it, the product quality is adequate, people are using it, and then you’re suddenly going to take it away? I mean, I think that that would create a public uproar.”.
VR Score
68
Informative language
71
Neutral language
22
Article tone
semi-formal
Language
English
Language complexity
63
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links